The state of Washington currently has 13 active clinical trials seeking participants for Alzheimer's Disease research studies. These trials are conducted in various cities, including Seattle, Spokane, Tacoma and Vancouver.
Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test
Recruiting
This observational, cross-sectional study is designed to validate a novel diagnostic test for the detection of phenotypic changes in the retina that correlate with likely PET amyloid status (negative or positive), to aid in the evaluation of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline. The CAS test is an adjunct to other diagnostic evaluations, and is indicated for use with the Optina Diagnostics' MHRC (K200254).
Gender:
All
Ages:
Between 50 years and 90 years
Trial Updated:
07/07/2023
Locations: University of Washington (MBWC), Seattle, Washington
Conditions: Alzheimer Disease, Mild Cognitive Impairment, Mild Dementia